Equine CA50 antibody and antigen (recombinant protein)
Diagnostic anti-Equine CA50 antibodies pairs and antigen for animal health (animal Equine/Horse pancreatic and colorectal cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-CA50-Ag01 | Equine CA50 | $3090.00 |
GMP-EQU-CA50-Ab01 | Anti-Equine CA50 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-CA50-Ab02 | Anti-Equine CA50 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-CA50-Ab03 | Anti-Equine CA50 human monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-CA50-Ab04 | Anti-Equine CA50 human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-EQU-CA50-Ag01 |
Product Name | Equine CA50 |
Target/Biomarker | Equine CA50 |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine CA50 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA50 level test of animal Equine/Horse with pancreatic and colorectal cancer. |
Tag | His | Reconized/Reactive Specics | Equine CA50 |
Product description | Recombinant Equine CA50 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-CA50-Ab01,GMP-EQU-CA50-Ab02 |
Target/Biomarker | Equine CA50 |
Product Name | Anti-Equine CA50 mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine CA50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA50 antibodies in Equine CA50 level test of animal Equine/Horse with pancreatic and colorectal cancer. |
Product description | Anti-Equine CA50 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA50 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-CA50-Ab03,GMP-EQU-CA50-Ab04 |
Target/Biomarker | Equine CA50 |
Product Name | Anti-Equine CA50 human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Equine CA50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA50 antibodies in Equine CA50 level test of animal Equine/Horse with pancreatic and colorectal cancer. |
Product description | Anti-Equine CA50 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Carbohydrate Antigen 50 (CA50) is a glycoprotein biomarker with vital implications in equine health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in horses, with a significant focus on those affecting the gastrointestinal and pancreatic regions. Structurally, CA50 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules.
In the context of equine health, elevated levels of CA50 in a horse's bloodstream can serve as a crucial indicator of the presence of specific cancers. The production and release of CA50 by cancer cells, especially those found in gastrointestinal and pancreatic cancers, lead to increased concentrations of this glycoprotein in the blood.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.